Cboe US - Delayed Quote USD

ARK Genomic Revolution ETF (ARKG)

23.62 +0.30 (+1.29%)
At close: April 22 at 4:00 PM EDT
23.64 +0.02 (+0.08%)
Pre-Market: 4:05 AM EDT

Top 10 Holdings (47.86% of Total Assets)

SymbolCompany% Assets
CRSP
CRISPR Therapeutics AG 7.22%
TWST
Twist Bioscience Corporation 5.88%
EXAS
Exact Sciences Corporation 5.45%
RXRX
Recursion Pharmaceuticals, Inc. 5.39%
BEAM
Beam Therapeutics Inc. 4.38%
SDGR
Schrödinger, Inc. 4.19%
NTLA
Intellia Therapeutics, Inc. 3.98%
CDNA
CareDx, Inc 3.83%
DNA
Ginkgo Bioworks Holdings, Inc. 3.79%
IONS
Ionis Pharmaceuticals, Inc. 3.74%

Sector Weightings

SectorARKG
Healthcare   98.17%
Technology   1.83%
Real Estate   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.80%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.38
Price/Sales 0.2
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

ETF Overview

Category Health
Fund Family ARK ETF Trust
Net Assets 1.61B
YTD Daily Total Return -28.01%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers